Susan Hasty, Publisher
Table of Contents . . . March 9th, 1998Non-Subscriber - Summaries Only
Conference Coverage (DHI Summit) - Hepatitis Coalition Launches 3 Year Education Initiative
Conference Coverage (DHI Summit) - Boomers Who Once Tried Drugs Have HCV Disease Risk
Conference Coverage (DHI Summit) - Country Star Says She's Cured of HCV
Conference Coverage (DHI Summit) - Hepatitis Funding on Rise, But More is Needed
Blood Safety (HCV) - $200 Million Shortfall in Hepatitis Deal, CBC Reports
Blood Safety (HCV) - Canadian Health Ministry Reports HCV-Tainted Blood Infected 60,000 to 90,000
Epidemiology (HAV) - The Netherlands Experiences Surge in Hepatitis A Cases
Hepatitis C Vaccine - Canadian Doctors Urge Caution Regarding Hungarian Claim of Hepatitis Cure
Hepatitis C Vaccine - Hepatitis Experts Wary of Cure Claim
Immunizations - U.S. Said Child Vaccinations At Record Levels
Therapy (Adverse Effects) - FDA Issues Warning about Duract (Bromfenac)
Vaccine Development - Hungarian and U.S. Physicians Claim New Hepatitis Cure
HCV Therapy (Interferon) - "Antibodies to E1 and E2 in Chronic HCV Patients with a Long-Term Response to Interferon Therapy."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.